​

Funding Round

Series C - HotSpot Therapeutics

Series C - HotSpot Therapeutics

Investment Firm

Overview

HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.

Announced Date

Nov 29, 2021

Funding Type

Series C

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Pivotal bioVenture Partners

Pivotal bioVenture Partners

Pivotal bioVenture Partners is a convertible_note and early_stage_venture and late_stage_venture and post_ipo firm.

Participant Investors

10

Investor Name
Participant InvestorSR One
Participant InvestorSofinnova Partners
Participant InvestorPivotal bioVenture Partners
Participant InvestorAtlas Venture
Participant InvestorB Capital

Round Details and Background

HotSpot Therapeutics raised $100000000 on 2021-11-29 in Series C

HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 17, 2018
Series A - HotSpot Therapeutics
2-45.0M
Mar 01, 2017
Seed Round - HotSpot Therapeutics
1-undefined
May 21, 2020
Series B - HotSpot Therapeutics
7-65.0M
Nov 29, 2021
Series C - HotSpot Therapeutics
10-100.0M

Recent Activity

There is no recent news or activity for this profile.